1Shimazui T, Schalken JA, Giroldi LA, et al. Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors. Cancer Res, 1996, 56:4154-4158.
2Hugh TJ, Dillon SA, Taylor BA, et al. Cadherin-catenin expression in primary colorectal cancer: a survival analysis. Br J Cancer, 1999, 80:1046-1051.
3Kowalski PJ, Rubin MA, Kleer CG. E-cadherin expression in primary carcinomas of the breast and its distant metastasis. Breast Cancer Res, 2003,5:217-222.
4Pedersen KB, Nesland JM, Fodstadφ, et al. Expression of S100A4,E-cadherin,α- and β-catenin in breast cancer biopsies. Br J Cancer, 2002,87:1281-1286.
5van de Wetering M, Barker N, Harkes IC, et al. Mutant E-cadherin breast cancer cells do not display constitutive Wnt signaling. Cancer Res,2001,61:278-284.
6Brabletz T, Jung A, Dag S, et al. β-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol,1999,155:1033-1038.
7Gilles C, Polette M, Mestdagt M, et al. Transactivation of vimentin by β-catenin in human breast cancer cells. Cancer Res,2003,63:2658-2664.
8Chang HJ, Jee CD, Kim WH. Mutation and altered expression of beta-catenin during gallbladder carcinogenesis[J].Am J Surg Pathol, 2002,26(6) :758
9Rashid A, Gao YT, Bhakta S, etal. Beta catenin mutations in biliary tract cancers: a population-based study in China[J].Cancer Res, 2001; 61(8) :3406
10Park WS, Oh RR, Park JY, et al. Frequent somatic mutations of the beta catenin gene in intestinal-type gastric cancer [J]. Cancer Res, 1999,59(17) :4257